Just In: FDA Panel Rejects Pfizer Booster Shot for Ages 16-65 Over Increased Risk of Heart Inflammation

On Friday, Biden’s vaccination plan hit a major roadblock after an FDA advisory panel declined to endorse authorization the Pfizer-BioNTech Covid booster shot for people aged 16 or older. The 18 member group of influential experts was tasked with deciding if Pfizer’s latest clinical trials had provided adequate results that demonstrate the safety and effectiveness … Continue reading Just In: FDA Panel Rejects Pfizer Booster Shot for Ages 16-65 Over Increased Risk of Heart Inflammation